These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 8001751

  • 1. [Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy].
    Sinn HP, Schmid H, Junkermann H, Huober J, Leppien G, Kaufmann M, Bastert G, Otto HF.
    Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):552-8. PubMed ID: 8001751
    [Abstract] [Full Text] [Related]

  • 2. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C, Tartter PI, Estabrook A, Gistrak MA, Jaffer S, Bleiweiss IJ.
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [Abstract] [Full Text] [Related]

  • 3. Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer.
    Peintinger F, Kuerer HM, McGuire SE, Bassett R, Pusztai L, Symmans WF.
    Br J Surg; 2008 Apr; 95(4):433-7. PubMed ID: 18161887
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer.
    Pierga JY, Mouret E, Diéras V, Laurence V, Beuzeboc P, Dorval T, Palangié T, Jouve M, Vincent-Salomon A, Scholl S, Extra JM, Asselain B, Pouillart P.
    Br J Cancer; 2000 Dec; 83(11):1480-7. PubMed ID: 11076657
    [Abstract] [Full Text] [Related]

  • 5. [Response evaluation with mammography and ultrasound].
    Junkermann H, Schmid H, Sinn HP, Wallwiener D.
    Zentralbl Gynakol; 1996 Dec; 118(10):572-3. PubMed ID: 8999712
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
    Botti C, Vici P, Lopez M, Scinto AF, Cognetti F, Cavaliere R.
    J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR, Romero AO, Pérez JE, Lacava JA, Domínguez ME, Rodríguez R, Barbieri MR, Romero Acuña LA, Romero Acuña JM, Langhi MJ, Amato S, Ortiz EH, Vallejo CT, Leone BA.
    Cancer J Sci Am; 1998 Sep; 4(2):125-31. PubMed ID: 9554929
    [Abstract] [Full Text] [Related]

  • 8. [Primary systemic therapy in breast cancer patients (2007-2010)].
    Zapf I, Tizedes G, Pavlovics G, Kovács G, Kálmán E, Szalai G, Kövér E, Farkas R, Horváth OP.
    Magy Seb; 2011 Oct; 64(5):223-8. PubMed ID: 21997525
    [Abstract] [Full Text] [Related]

  • 9. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.
    Cameron DA, Gregory WM, Bowman A, Anderson ED, Levack P, Forouhi P, Leonard RC.
    Br J Cancer; 2000 Jul; 83(1):98-103. PubMed ID: 10883676
    [Abstract] [Full Text] [Related]

  • 13. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
    Sullivan PS, Apple SK.
    Breast J; 2009 Jul; 15(2):146-54. PubMed ID: 19292800
    [Abstract] [Full Text] [Related]

  • 14. Breast conservation after induction chemotherapy for locally advanced breast cancer.
    Kling KM, Ostrzega N, Schmit P.
    Am Surg; 1997 Oct; 63(10):861-4. PubMed ID: 9322658
    [Abstract] [Full Text] [Related]

  • 15. Determining the morphological features of breast cancer and predicting the effects of neoadjuvant chemotherapy via diagnostic breast imaging.
    Tsunoda-Shimizu H, Hayashi N, Hamaoka T, Kawasaki T, Tsugawa K, Yagata H, Kikuchi M, Suzuki K, Nakamura S.
    Breast Cancer; 2008 Oct; 15(2):133-40. PubMed ID: 18288570
    [Abstract] [Full Text] [Related]

  • 16. Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response.
    Rajan R, Poniecka A, Smith TL, Yang Y, Frye D, Pusztai L, Fiterman DJ, Gal-Gombos E, Whitman G, Rouzier R, Green M, Kuerer H, Buzdar AU, Hortobagyi GN, Symmans WF.
    Cancer; 2004 Apr 01; 100(7):1365-73. PubMed ID: 15042669
    [Abstract] [Full Text] [Related]

  • 17. Chemotherapy and concomitant irradiation in inflammatory breast cancer.
    Tubiana-Mathieu N, Lejeune C, Bonnier P, Genet D, Adjadj DJ, Berda JF, Muracciole X, Delaby F, Clavere P, Benyoub A, Rhein B, Juin B, Piana L.
    Anticancer Res; 2001 Apr 01; 21(4B):3061-7. PubMed ID: 11712811
    [Abstract] [Full Text] [Related]

  • 18. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M, Rodríguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Munárriz B, Rodríguez CA, Crespo C, de Alava E, López García-Asenjo JA, Guitián MD, Almenar S, González-Palacios JF, Vera F, Palacios J, Ramos M, Gracia Marco JM, Lluch A, Alvarez I, Seguí MA, Mayordomo JI, Antón A, Baena JM, Plazaola A, Modolell A, Pelegrí A, Mel JR, Aranda E, Adrover E, Alvarez JV, García Puche JL, Sánchez-Rovira P, Gonzalez S, López-Vega JM, GEICAM 9906 Study Investigators.
    J Natl Cancer Inst; 2008 Jun 04; 100(11):805-14. PubMed ID: 18505968
    [Abstract] [Full Text] [Related]

  • 19. Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trial.
    Loibl S, von Minckwitz G, Raab G, Blohmer JU, Dan Costa S, Gerber B, Eidtmann H, Petrich S, Hilfrich J, Jackisch C, du Bois A, Kaufmann M.
    Ann Surg Oncol; 2006 Nov 04; 13(11):1434-42. PubMed ID: 16983592
    [Abstract] [Full Text] [Related]

  • 20. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.
    Sataloff DM, Mason BA, Prestipino AJ, Seinige UL, Lieber CP, Baloch Z.
    J Am Coll Surg; 1995 Mar 04; 180(3):297-306. PubMed ID: 7874340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.